Retrospective Study
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Sep 7, 2014; 20(33): 11815-11825
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11815
Non invasive blood flow measurement in cerebellum detects minimal hepatic encephalopathy earlier than psychometric tests
Vicente Felipo, Amparo Urios, Carla Giménez-Garzó, Omar Cauli, Maria-Jesús Andrés-Costa, Olga González, Miguel A Serra, Javier Sánchez-González, Roberto Aliaga, Remedios Giner-Durán, Vicente Belloch, Carmina Montoliu
Vicente Felipo, Carla Giménez-Garzó, Omar Cauli, Laboratory of Neurobiology, Centro Investigación Príncipe Felipe, 46012 Valencia, Spain
Amparo Urios, Maria-Jesús Andrés-Costa, Carmina Montoliu, Fundación Investigación Hospital Clínico de Valencia. Instituto de Investigación Sanitaria, INCLIVA, 46010 Valencia, Spain
Olga González, Remedios Giner-Durán, Servicio Digestivo, Hospital Arnau de Vilanova, 46015 Valencia, Spain
Miguel A Serra, Grupo Hepatología, Servicio Aparato Digestivo, Hospital Clínico de Valencia, 46010 Valencia, Spain
Javier Sánchez-González, Philips Healthcare, Iberia, 28050 Madrid, Spain
Roberto Aliaga, Vicente Belloch, ERESA, Unidad RM, 46015 Valencia, Spain
Roberto Aliaga, Vicente Belloch, Departamento de Patología, Facultad de Medicina, Universidad de Valencia, 46010 Valencia, Spain
Author contributions: Urios A, Giménez-Garzó C, Cauli O and Andrés-Costa MJ performed psychometric tests, biochemical determinations, and analysis of blood flow in brain areas; González O, Serra MA, and Giner-Durán R selected of patients and provided the analytical data; Sánchez-González J designed the homemade software for blood flow analysis; Aliaga R and Belloch V contributed to magnetic resonance acquisition, interpretation of data, revising the manuscript; Felipo V and Montoliu C designed the study, obtained funding, performed analysis and interpretation of data and wrote the paper; all authors approved the final version of the article.
Supported by Ministerio de Ciencia e Innovación, Nos. FIS PS09/00806; FIS PI12/00884 to Montoliu C; SAF2011-23051, CSD2008-00005 to Felipo V; Consellería de Educación Generalitat Valenciana, Nos. PROMETEO-2009-027, ACOMP/2012/066 to Felipo V, No. ACOMP/2012/056 to Montoliu C; Sanitat, No. AP-004/11 to Felipo V, AP-087/11 to Montoliu C; Fundación ERESA to Montoliu C
Correspondence to: Carmina Montoliu, PhD, Fundación Investigación Hospital Clínico de Valencia. Instituto de Investigación Sanitaria, INCLIVA, , Avda Blasco Ibañez, 17, 46010 Valencia, Spain. cmontoliu@incliva.es
Telephone: +34-96-3864381  Fax: +34-96-3289701
Received: November 7, 2013
Revised: February 23, 2014
Accepted: May 19, 2014
Published online: September 7, 2014
Abstract

AIM: To assess whether non invasive blood flow measurement by arterial spin labeling in several brain regions detects minimal hepatic encephalopathy.

METHODS: Blood flow (BF) was analyzed by arterial spin labeling (ASL) in different brain areas of 14 controls, 24 cirrhotic patients without and 16 cirrhotic patients with minimal hepatic encephalopathy (MHE). Images were collected using a 3 Tesla MR scanner (Achieva 3T-TX, Philips, Netherlands). Pulsed ASL was performed. Patients showing MHE were detected using the battery Psychometric Hepatic Encephalopathy Score (PHES) consisting of five tests. Different cognitive and motor functions were also assessed: alterations in selective attention were evaluated using the Stroop test. Patients and controls also performed visuo-motor and bimanual coordination tests. Several biochemical parameters were measured: serum pro-inflammatory interleukins (IL-6 and IL-18), 3-nitrotyrosine, cGMP and nitrates+nitrites in plasma, and blood ammonia. Bivariate correlations were evaluated.

RESULTS: In patients with MHE, BF was increased in cerebellar hemisphere (P = 0.03) and vermis (P = 0.012) and reduced in occipital lobe (P = 0.017). BF in cerebellar hemisphere was also increased in patients without MHE (P = 0.02). Bimanual coordination was impaired in patients without MHE (P = 0.05) and much more in patients with MHE (P < 0.0001). Visuo-motor coordination was impaired only in patients with MHE (P < 0.0001). Attention was slightly affected in patients without MHE and more strongly in patients with MHE (P < 0.0001). BF in cerebellar hemisphere and vermis correlated with performance in most tests of PHES [(number connection tests A (NCT-A), B (NCT-B)and line tracing test] and in the congruent task of Stroop test. BF in frontal lobe correlated with NCT-A. Performance in bimanual and visuomotor coordination tests correlated only with BF in cerebellar hemisphere. BF in occipital lobe correlates with performance in the PHES battery and with CFF. BF in cerebellar hemisphere correlates with plasma cGMP and nitric oxide (NO) metabolites. BF in vermis cerebellar also correlates with NO metabolites and with 3-nitrotyrosine. IL-18 in plasma correlates with BF in thalamus and occipital lobe.

CONCLUSION: Non invasive BF determination in cerebellum using ASL may detect MHE earlier than the PHES. Altered NO-cGMP pathway seems to be associated to altered BF in cerebellum.

Keywords: Arterial spin labelling, Neurological impairment, Blood flow, Cerebellum, Minimal hepatic encephalopathy

Core tip: Patients with minimal hepatic encephalopathy (MHE) show neurological impairment in specific tasks to which selective regional alterations in blood flow (BF) could contribute. Arterial spin labeling (ASL), a non-invasive magnetic resonance technique, quantitatively measures cerebral perfusion. We analyzed BF by ASL in different brain areas of controls and cirrhotic patients without and with MHE. We found that BF is more affected in cerebellum than in other areas of cirrhotic patients and that BF determination in cerebellum using ASL may detect MHE earlier than the Psychometric Hepatic Encephalopathy Score battery. Altered nitric oxide-cGMP pathway seems to be associated to altered BF in cerebellum.